在存活精神分裂症患者亚群中,嗅神经元细胞中鉴定的蛋白质聚集与认知损害相关
精神分裂症具有异质性,蛋白质稳态破坏导致的蛋白质聚集是其较新的病理生理假说。本研究利用存活精神分裂症患者来源的嗅神经元细胞,发现一部分患者存在蛋白质聚集(不溶性蛋白和泛素化增加、泛素阳性蛋白聚集体),且这些患者比无聚集者表现出更严重的认知缺陷。
要点
- 存活精神分裂症患者来源的嗅神经元细胞中,一部分患者显示蛋白质聚集。
- 蛋白质聚集表现为不溶性蛋白增加、不溶性蛋白组分泛素化增加及泛素阳性蛋白聚集体。
- 有蛋白质聚集的患者比无聚集者表现出更严重的认知缺陷。
核心结论
- 与死后脑组织类似,一部分精神分裂症患者的嗅神经元存在蛋白质聚集,且聚集与更严重的认知缺陷相关。
研究设计与样本
- 研究采用存活精神分裂症患者来源的嗅神经元细胞作为独立模型系统,检测蛋白质聚集并分析其与患者临床和认知状态的关系。
主要发现
- 一部分精神分裂症患者的嗅神经元表现出蛋白质聚集,证据为不溶性蛋白增加、不溶性蛋白组分泛素化增加及泛素阳性蛋白聚集体。
- 有蛋白质聚集的患者比无聚集的患者表现出更严重的认知缺陷,组间比较和相关性分析均显示此结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia is a heterogeneous disorder, and likely results from multiple pathophysiological mechanisms. Protein aggregation, resulting from disruption of protein homeostasis (proteostasis), has been implicated in many diseases, including cancer, cardiac and pulmonary diseases, muscle diseases, and neurodegenerative disorders, but is a relatively new pathophysiological hypothesis for schizophrenia. Genetic findings implicate proteostasis in schizophrenia, and individual proteins associated with the disorder may undergo aggregation. While there is some evidence of associations between genetic variants and protein aggregation, the extent to which genetic variations influence protein aggregation remains unknown. We have previously reported increased protein insolubility and increased ubiquitination of the insoluble protein fraction, two markers of protein aggregation, in human postmortem brains from a subset of patients with schizophrenia. In the present study, we investigate whether protein aggregation is observed in an independent model system, olfactory neuronal cells derived from living patients with schizophrenia, and examine the relationship between aggregation and patient clinical and cognitive status. We demonstrate that, as in postmortem brain, olfactory neurons from a subset of patients with schizophrenia exhibit protein aggregation, identified by increased protein insolubility and ubiquitination of the insoluble protein fraction, and by ubiquitin positive protein aggregates. Patients with protein aggregation exhibit more severe cognitive deficits than those without aggregation, as revealed by between-group comparisons and correlational analyses. Understanding the mechanisms of the aggregation process, the factors that differentiate individuals who develop aggregates from those who do not, and the relationship between aggregation and cell function, has important implications for the pathophysiology of schizophrenia, and may provide insight into disease heterogeneity and novel therapeutic targets.
引用
- Nucifora LG, Ishizuka K, El Demerdash N, et al. Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patients. Mol Psychiatry. 2025. PMID: 40181190. doi:10.1038/s41380-025-02956-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。